Petri Salvén

6.3k total citations
50 papers, 5.1k citations indexed

About

Petri Salvén is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Petri Salvén has authored 50 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 32 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Petri Salvén's work include Angiogenesis and VEGF in Cancer (37 papers), Lymphatic System and Diseases (14 papers) and Vascular Tumors and Angiosarcomas (11 papers). Petri Salvén is often cited by papers focused on Angiogenesis and VEGF in Cancer (37 papers), Lymphatic System and Diseases (14 papers) and Vascular Tumors and Angiosarcomas (11 papers). Petri Salvén collaborates with scholars based in Finland, United States and Sweden. Petri Salvén's co-authors include Heikki Joensuu, Kari Alitalo, Arto Orpana, Lasse Teerenhovi, Päivi Heikkilä, Iiro Rajantie, Shahin Rafii, Riitta Alitalo, Tarja Ruotsalainen and Shentong Fang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cell Metabolism.

In The Last Decade

Petri Salvén

49 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petri Salvén Finland 29 3.4k 2.4k 1.1k 528 507 50 5.1k
Carl‐Henrik Heldin Sweden 23 4.0k 1.2× 1.3k 0.5× 664 0.6× 395 0.7× 365 0.7× 29 5.7k
Jacob Pe’er Israel 39 3.6k 1.1× 1.8k 0.7× 1.2k 1.1× 486 0.9× 245 0.5× 149 7.7k
Brett M. Hall United States 22 2.0k 0.6× 2.1k 0.9× 1.0k 1.0× 528 1.0× 1.3k 2.5× 43 4.7k
Gerald Wulf Germany 32 2.9k 0.8× 1.9k 0.8× 849 0.8× 531 1.0× 771 1.5× 152 5.3k
Svetlana Pack United States 47 3.1k 0.9× 1.5k 0.6× 1.1k 1.0× 933 1.8× 467 0.9× 130 6.5k
Suk‐Chul Bae South Korea 40 4.6k 1.3× 1.4k 0.6× 1.0k 0.9× 589 1.1× 318 0.6× 78 6.1k
Florian Otto Germany 24 3.1k 0.9× 1.4k 0.6× 814 0.7× 410 0.8× 288 0.6× 35 4.9k
Tetsuro Watabe Japan 44 4.6k 1.3× 1.7k 0.7× 787 0.7× 821 1.6× 461 0.9× 108 6.9k
Klaus Elenius Finland 44 3.4k 1.0× 2.6k 1.1× 737 0.7× 424 0.8× 324 0.6× 105 6.2k
Bronislaw Pytowski United States 37 3.5k 1.0× 3.6k 1.5× 741 0.7× 1.1k 2.1× 350 0.7× 61 6.5k

Countries citing papers authored by Petri Salvén

Since Specialization
Citations

This map shows the geographic impact of Petri Salvén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petri Salvén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petri Salvén more than expected).

Fields of papers citing papers by Petri Salvén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petri Salvén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petri Salvén. The network helps show where Petri Salvén may publish in the future.

Co-authorship network of co-authors of Petri Salvén

This figure shows the co-authorship network connecting the top 25 collaborators of Petri Salvén. A scholar is included among the top collaborators of Petri Salvén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petri Salvén. Petri Salvén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loukovaara, Sirpa, Erika Gucciardo, Pauliina Repo, et al.. (2015). Indications of lymphatic endothelial differentiation and endothelial progenitor cell activation in the pathology of proliferative diabetic retinopathy. Acta Ophthalmologica. 93(6). 512–523. 24 indexed citations
2.
Glumoff, Virpi, et al.. (2013). TIM-family molecules in embryonic hematopoiesis: Fetal liver TIM-4lo cells have myeloid potential. Experimental Hematology. 42(3). 230–240. 6 indexed citations
3.
Fang, Shentong, et al.. (2012). Generation of Functional Blood Vessels from a Single c-kit+ Adult Vascular Endothelial Stem Cell. PLoS Biology. 10(10). e1001407–e1001407. 122 indexed citations
4.
5.
Fang, Shentong & Petri Salvén. (2010). Stem cells in tumor angiogenesis. Journal of Molecular and Cellular Cardiology. 50(2). 290–295. 51 indexed citations
6.
Lauttia, Susanna, Na Zhang, Denis Tvorogov, et al.. (2009). The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels. Microvascular Research. 78(3). 278–285. 28 indexed citations
7.
Rossi, Derrick J., Iiro Rajantie, Seppo Ylä‐Herttuala, et al.. (2008). Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proceedings of the National Academy of Sciences. 105(18). 6620–6625. 294 indexed citations
8.
Orpana, Arto & Petri Salvén. (2002). Angiogenic and Lymphangiogenic Molecules in Hematological Malignancies. Leukemia & lymphoma. 43(2). 219–224. 25 indexed citations
9.
Repo, Heikki, Sami Kilpinen, Aarno Palotie, et al.. (2002). CD14 and TNFα promoter polymorphisms in patients with acute arthritis. Scandinavian Journal of Rheumatology. 31(6). 355–361. 9 indexed citations
10.
Salvén, Petri. (2001). Angiogenesis in Lymphoproliferative Disorders. Acta Haematologica. 106(4). 184–189. 16 indexed citations
11.
Niemelä, Mika, Hanna Mäenpää, Petri Salvén, et al.. (2001). Interferon alpha-2a therapy in 18 hemangioblastomas.. PubMed. 7(3). 510–6. 32 indexed citations
12.
13.
Salvén, Petri, Päivi Heikkilä, Jussi Taipale, et al.. (1999). VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer. American Journal Of Pathology. 154(5). 1381–1390. 460 indexed citations
14.
Salvén, Petri, Vesa Perhoniemi, H Tykkä, Hanna Mäenpää, & Heikki Joensuu. (1999). Serum VEGF levels in women with a benign breast tumor or breast cancer. Breast Cancer Research and Treatment. 53(2). 161–166. 103 indexed citations
15.
Salvén, Petri, Athina Lymboussaki, Päivi Heikkilä, et al.. (1998). Vascular Endothelial Growth Factors VEGF-B and VEGF-C Are Expressed in Human Tumors. American Journal Of Pathology. 153(1). 103–108. 277 indexed citations
16.
Wartiovaara, Ulla, Petri Salvén, Hanna Mikkola, et al.. (1998). Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Journal of Thrombosis and Haemostasis. 80. 171–175. 2 indexed citations
17.
Salvén, Petri, Tarja Ruotsalainen, Karin Mattson, & Heikki Joensuu. (1998). High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer. International Journal of Cancer. 79(2). 144–146. 232 indexed citations
18.
Salvén, Petri, Päivi Heikkilä, & Heikki Joensuu. (1997). Enhanced expression of vascular endothelial growth factor in metastatic melanoma. British Journal of Cancer. 76(7). 930–934. 121 indexed citations
19.
Salvén, Petri, Lasse Teerenhovi, & Heikki Joensuu. (1997). A High Pretreatment Serum Vascular Endothelial Growth Factor Concentration Is Associated With Poor Outcome in Non-Hodgkin's Lymphoma. Blood. 90(8). 3167–3172. 231 indexed citations
20.
Salvén, Petri, et al.. (1996). Endothelial Tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis. British Journal of Cancer. 74(1). 69–72. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl‐Henrik Heldin Breakdown of academic impact, for papers by Jacob Pe’er Breakdown of academic impact, for papers by Brett M. Hall Breakdown of academic impact, for papers by Gerald Wulf Breakdown of academic impact, for papers by Svetlana Pack Breakdown of academic impact, for papers by Suk‐Chul Bae Breakdown of academic impact, for papers by Florian Otto Breakdown of academic impact, for papers by Tetsuro Watabe Breakdown of academic impact, for papers by Klaus Elenius Breakdown of academic impact, for papers by Bronislaw Pytowski
Rankless by CCL
2026